Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-22T14:24:20.775Z Has data issue: false hasContentIssue false
  • English
  • Français

Diagnosis and treatment of akathisia in a cancer patient who cannot stand up or sit down, because of poor performance status: Factors that make the diagnosis of akathisia difficult, and diagnosis clues

Published online by Cambridge University Press:  28 September 2010

Hideki Onishi ,
Makoto Wada ,
Tomomi Wada ,
Mei Wada ,
Mayumi Ishida ,
Chiaki Kawanishi ,
Keiko Mizuno ,
Hiroshi Ito ,
Masaru Narabayashi  and
Yasutsuna Sasaki
Hideki Onishi*
Affiliation:
Department of Psycho-Oncology, Saitama Medical University, Japan
Makoto Wada
Affiliation:
Department of Psycho-Oncology, Saitama Medical University, Japan
Tomomi Wada
Affiliation:
Department of Psycho-Oncology, Saitama Medical University, Japan
Mei Wada
Affiliation:
Department of Psycho-Oncology, Saitama Medical University, Japan
Mayumi Ishida
Affiliation:
Graduate School of Human Sciences, Waseda University, Japan
Chiaki Kawanishi
Affiliation:
Department of Psychiatry, Yokohama City University, Japan
Keiko Mizuno
Affiliation:
Department of Clinical Oncology, Saitama Medical University, Japan
Hiroshi Ito
Affiliation:
Department of Clinical Oncology, Saitama Medical University, Japan
Masaru Narabayashi
Affiliation:
Department of Clinical Oncology, Saitama Medical University, Japan
Yasutsuna Sasaki
Affiliation:
Department of Clinical Oncology, Saitama Medical University, Japan
*
Address correspondence and reprint requests to: Hideki Onishi, Department of Psycho-Oncology, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Akathisia is a common adverse effect of antipsychotics and, less commonly, antidepressants. Akathisia can cause great discomfort and is often described by the patient as a most distressing sensation; however, the condition is often underdiagnosed or misdiagnosed. In oncological settings, neuroleptics and antidepressants that induce akathisia are also administered. However, reports of akathisia in oncology settings are few and a case of akathisia in a bedridden patient has not been reported as far as we know.

Case report:

A 72-year-old man with esophageal cancer who could not sit down or stand up was administered 5 mg/day haloperidol to relieve agitation as a symptom of major depressive disorder. Three days after the administration of haloperidol, the agitation had become worse. Careful observation revealed that the patient sometimes showed slight rubbing movement of the lower extremities and slight twisting movements of the body, which were not observed before the administration of haloperidol. The patient moved his body and lower extremities to relieve restlessness, which had developed after the administration of haloperidol. Although symptoms were atypical, akathisia was suspected and discontinuation of haloperidol resolved the symptoms.

Results and significance of results:

In patients with poor performance status, clues leading to the correct diagnosis of akathisia might be absent, which would not be the case in patients who were able to walk, stand up, or sit down. Careful observations of patients before and after the administration of drugs that may cause akathisia may be required to ensure correct diagnosis.

Keywords

CancerAkathisiaPoor performance status
Type
Case Report
Information
Palliative & Supportive Care , Volume 8 , Issue 4 , December 2010 , pp. 477 - 480
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders. Washington, D.C.: American Psychiatric Press.Google Scholar
Atbasoglu, E., Schultz, S. K. & Andreasen, N. C. (2001). The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences, 13, 336–341.CrossRefGoogle Scholar
Botney, M. & Fields, H.L. (1983). Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Annals of Neurology, 13, 160–164.CrossRefGoogle ScholarPubMed
Fleishman, S.B., Lavin, M.R., Sattler, M. et al. (1994). Antiemetic-induced akathisia in cancer patients receiving chemotherapy. American Journal of Psychiatry, 151, 763–765.Google ScholarPubMed
Francis, J., Martin, D. & Kapoor, W.N. (1990). A prospective study of delirium in hospitalized elderly. Journal of the American Medical Association, 263, 1097–1101.CrossRefGoogle ScholarPubMed
Hamon, M., Gozlan, H., Bourgoin, S., et al. (1987). Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline. Neuropharmacology, 26, 531–539.CrossRefGoogle ScholarPubMed
Hirose, S. (2003). The causes of underdiagnosing akathisia. Schizophrenia Bulletin, 29, 547–558.CrossRefGoogle ScholarPubMed
Hsin-Tung, E. & Simpson, G.M. (2000). Medication-induced movement disorders. In Comprehensive Textbook of Psychiatry. Sadock, B. & Sadock, V.A . (eds.). Philadelphia: Lippincott Williams & Wilkins, 2265–2271.Google Scholar
Kawanishi, C., Onishi, H., Kato, D., et al. (2007). Unexpectedly high prevalence of akathisia in cancer patients. Palliative & Support Care, 5, 351–354.CrossRefGoogle ScholarPubMed
Khawam, E.A., Laurencic, G. & Malone, D.A. Jr., (2006). Side effects of antidepressants: an overview. Cleveland Clinic Journal of Medicine, 73, 351–353.CrossRefGoogle ScholarPubMed
Magni, G., Conlon, P. & Arsie, D. (1987). Tricyclic antidepressants in the treatment of cancer pain: A review. Pharmacopsychiatry, 20, 160–164.CrossRefGoogle ScholarPubMed
Mannix, K.A. (1999). Palliation of nausea and vomiting. In Oxford Textbook of Palliative Medicine, Doyle, D., Hanks, G.W.C. & MacDonald, N. (eds.). pp. 489–499. New York: Oxford University Press.Google Scholar
Meagher, D.J. (2001). Delirium: Optimising management. British Medical Journal, 322, 144–149.CrossRefGoogle ScholarPubMed
O'Hara, V.S. (1958). Extrapyramidal reactions in patients receiving prochlorperazine. New England Journal of Medicine, 259, 826–828.CrossRefGoogle ScholarPubMed
Oken, M.M., Creech, R.H., Tormey, D.C., et al. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5, 649–655.CrossRefGoogle ScholarPubMed
Onishi, H., Yamamoto, W., Wada, M., et al. (2007). Detection and treatment of akathisia in advanced cancer patients during adjuvant analgesic therapy with tricyclic antidepressants: Case reports and review of the literature. Palliative & Supportive Care, 5, 411–414.CrossRefGoogle ScholarPubMed
Rodgers, C. (1992). Extrapyramidal side effects of antiemetics presenting as psychiatric illness. General Hospital Psychiatry, 14, 192–195.CrossRefGoogle ScholarPubMed
Shear, M.K., Frances, A. & Weiden, P. (1983). Suicide associated with akathisia and depot fluphenazine treatment. Journal of Clinical Psychopharmacology, 3, 235–236.CrossRefGoogle ScholarPubMed
Siris, S.G. (1985). Three cases of akathisia and “acting out.” Journal of Clinical Psychopharmacology, 46, 395–397.Google ScholarPubMed
Sunakawa, Y., Wada, M., Nishida, T., et al. (2008). A case of respiratory akathisia in a cancer patient: a case report. Palliative & Supportive Care, 6, 79–81.CrossRefGoogle Scholar